phrykt

Medpace Holdings, Inc. (MEDP): who owns it and who trades it

As of Nov 16, 2026, MEDP insiders reported 50 open-market sales worth $411M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was August J. Troendle (CEO), with $343M. 9 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Medpace Holdings

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns MEDP

695 funds and institutions reported MEDP shares worth $13.2B at the end of Q2 2026, about 87% of the company. The largest holder is BlackRock, Inc. with 8.7%.

Funds and institutions (13F) 87%Everyone else 13%

10 largest owners, by share of the company

BlackRock, Inc.8.7%
T. Rowe Price Associates7.2%
AQR Capital Management LLC4.5%
Vanguard Portfolio Management LLC4.0%
Vanguard Capital Management LLC3.6%
State Street Corp2.5%
Geode Capital Management, LLC2.5%
Wasatch Advisors LP2.2%
Invesco Ltd.2.0%
Baillie Gifford & Co1.7%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.2.50M8.75%$1.3B+1%
T. Rowe Price Associates2.07M7.25%$1.1B+615%
AQR Capital Management LLC1.28M4.48%$677M-6%
Vanguard Portfolio Management LLC1.13M3.97%$600M+1%
Vanguard Capital Management LLC1.03M3.60%$544M+2%
State Street Corp710,8952.49%$376M+4%
Geode Capital Management, LLC710,4652.49%$376M-5%
Wasatch Advisors LP636,5952.23%$337M-18%
Invesco Ltd.579,2412.03%$307M+0%
Baillie Gifford & Co473,2111.66%$251M-6%
Arrowstreet Capital, Limited Partnership429,0121.50%$227M+8%
Renaissance Technologies LLC415,5881.46%$220M-18%
Dimensional Fund Advisors LP397,5001.39%$211M+14%
Morgan Stanley317,5481.11%$168M+10%
UBS Group AG303,9261.06%$161M-11%
Bessemer Group Inc282,8970.99%$150M-1%
Mawer Investment Management Ltd.267,1750.94%$141M-40%
Epoch Investment Partners, Inc.266,5470.93%$141M+89%
TD Asset Management Inc263,8720.92%$140M+98%
Thrivent Financial for Lutherans256,3410.90%$136M+11%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, MEDP insiders reported $0 of open-market purchases and $411M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$411M
50 trades, 9 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Oct 29, 2026
Filed Nov 2, 2026

Purchases and sales by month

$126M$126MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 29, 2026Stephen P EwaldGeneral Counsel & Corp. Sale1,245$690.00$859KForm 4
Oct 27, 2026Susan E BurwigVice presidentSale3,940$677.00$2.7MForm 4
Oct 26, 2026Susan E BurwigVice presidentSale16,060$677.00$10.9MForm 4
Sep 30, 2026August J. TroendleCEOSale21,966$625.47$13.7MForm 4
Sep 29, 2026August J. TroendleCEOSale26,701$621.02$16.6MForm 4
Sep 28, 2026August J. TroendleCEOSale2,410$620.07$1.5MForm 4
Sep 25, 2026August J. TroendleCEOSale154$620.60$95.6KForm 4
Sep 24, 2026August J. TroendleCEOSale27,833$621.33$17.3MForm 4
Sep 23, 2026August J. TroendleCEOSale16,083$628.64$10.1MForm 4
Sep 22, 2026August J. TroendleCEOSale49,018$628.11$30.8MForm 4
Sep 21, 2026August J. TroendleCEOSale21,883$623.29$13.6MForm 4
Sep 17, 2026August J. TroendleCEOSale10,880$620.40$6.7MForm 4
Sep 16, 2026August J. TroendleCEOSale8,770$621.29$5.4MForm 4
Sep 15, 2026August J. TroendleCEOSale15,971$620.84$9.9MForm 4
Aug 27, 2026August J. TroendleCEOSale650$620.27$403KForm 4
Aug 26, 2026Robert O. KraftDirectorSale3,858$617.81$2.4MForm 4
Aug 26, 2026August J. TroendleCEOSale4,000$620.03$2.5MForm 4
Aug 25, 2026August J. TroendleCEOSale673$620.38$418KForm 4
Aug 24, 2026August J. TroendleCEOSale1,983$620.23$1.2MForm 4
Aug 21, 2026August J. TroendleCEOSale13,995$624.45$8.7MForm 4
Aug 20, 2026Kevin M. BradyCFOSale3,400$625.24$2.1MForm 4
Aug 20, 2026August J. TroendleCEOSale27,174$618.79$16.8MForm 4
Aug 19, 2026August J. TroendleCEOSale15,609$606.47$9.5MForm 4
Aug 19, 2026Brian T CarleyDirectorSale5,000$608.63$3MForm 4
Aug 19, 2026Fred B Davenport JrDirectorSale7,283$606.15$4.4MForm 4
Aug 13, 2026August J. TroendleCEOSale458$600.39$275KForm 4
Aug 12, 2026August J. TroendleCEOSale11,366$601.53$6.8MForm 4
Aug 11, 2026Cornelius P. McCarthy IIIDirectorSale1,140$605.37$690KForm 4
Aug 11, 2026August J. TroendleCEOSale17,610$605.11$10.7MForm 4
Aug 10, 2026August J. TroendleCEOSale5,534$601.53$3.3MForm 4
Aug 7, 2026Cornelius P. McCarthy IIIDirectorSale795$585.07$465KForm 4
Jul 28, 2026August J. TroendleCEOSale3,510$600.01$2.1MForm 4
Jul 28, 2026Susan E BurwigVice presidentSale7,500$600.00$4.5MForm 4
Jul 27, 2026August J. TroendleCEOSale3,728$600.85$2.2MForm 4
May 28, 2026Stephen P EwaldGeneral Counsel & Corp. Sale16,349$450.00$7.4MForm 4
Mar 17, 2026Jesse J GeigerPresidentSale31,707$455.30$14.4MForm 4
Dec 3, 2025August J. TroendleCEOSale668$590.69$395KForm 4
Dec 2, 2025August J. TroendleCEOSale5,698$590.47$3.4MForm 4
Dec 1, 2025August J. TroendleCEOSale23,178$593.25$13.8MForm 4
Nov 28, 2025August J. TroendleCEOSale15,151$593.46$9MForm 4
Nov 26, 2025August J. TroendleCEOSale41,331$606.88$25.1MForm 4
Nov 25, 2025August J. TroendleCEOSale42,392$615.52$26.1MForm 4
Nov 24, 2025August J. TroendleCEOSale59,025$607.78$35.9MForm 4
Nov 24, 2025Susan E BurwigVice presidentSale20,000$609.15$12.2MForm 4
Nov 21, 2025Kevin M. BradyCFOSale3,000$590.35$1.8MForm 4
Nov 21, 2025August J. TroendleCEOSale21,858$592.18$12.9MForm 4
Nov 20, 2025August J. TroendleCEOSale6,830$598.49$4.1MForm 4
Nov 19, 2025August J. TroendleCEOSale23,862$592.07$14.1MForm 4
Nov 18, 2025August J. TroendleCEOSale7,191$590.84$4.2MForm 4
Nov 17, 2025August J. TroendleCEOSale6,047$591.00$3.6MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
August J. TroendleCEO, Director, 10% owner–$343MSep 30, 2026
Susan E BurwigExec. VP, Operations–$30.2MOct 27, 2026
Jesse J GeigerPresident–$14.4MMar 17, 2026
Stephen P EwaldGeneral Counsel & Corp. Secy.–$8.2MOct 29, 2026
Fred B Davenport JrDirector–$4.4MAug 19, 2026
Kevin M. BradyCFO & Treasurer–$3.9MAug 20, 2026
Brian T CarleyDirector–$3MAug 19, 2026
Robert O. KraftDirector–$2.4MAug 26, 2026
Cornelius P. McCarthy IIIDirector–$1.2MAug 11, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MEDP short interest

Low short interest. 4.9% of MEDP shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went down 27%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.38M MEDP shares were sold short, 4.9% of the shares outstanding, down 14.1% from the report before. At the average daily volume of 399,615 shares, buying them all back would take about 3.5 trading days (days to cover).

Shares short, % of all shares

4.95%May 15Oct 308.08%

Days to cover

3.5May 15Oct 309.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.38M4.95%-14%399,6153.5
Oct 15, 20261.61M5.78%+1%244,8056.6
Sep 30, 20261.60M5.72%-5%275,4425.8
Sep 15, 20261.69M6.04%+1%191,0148.8
Aug 31, 20261.67M5.99%+6%203,1388.2
Aug 14, 20261.58M5.66%-10%206,6227.6
Jul 31, 20261.75M6.26%-20%457,8853.8
Jul 15, 20262.19M7.67%+3%298,8787.3
Jun 30, 20262.13M7.44%+2%362,7485.9
Jun 15, 20262.09M7.31%+2%248,4778.4
May 29, 20262.05M7.20%+8%307,0306.7
May 15, 20261.90M6.67%+23%347,2815.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded MEDP

Since Nov 17, 2024, 4 members of Congress reported 4 purchases and 7 sales of MEDP. The latest was a purchase by David J. Taylor on May 15, 2026, reported May 28, 2026.

Purchases 4Sales 7

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
May 15, 2026David J. Taylor (R-OH)Purchase$1K–$15KSelfMay 28, 2026Report
Feb 26, 2026David J. Taylor (R-OH)Purchase$1K–$15KSelfMar 6, 2026Report
Jan 29, 2026David J. Taylor (R-OH)Purchase$1K–$15KSelfFeb 2, 2026Report
Jan 16, 2026David J. Taylor (R-OH)Sale$1K–$15KSelfFeb 2, 2026Report
Jan 15, 2026Gilbert Ray Cisneros, Jr. (D-CA)Sale$15K–$50KSelfFeb 13, 2026Report
Oct 9, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfNov 18, 2025Report
Aug 4, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseSep 12, 2025Report
Jul 24, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfAug 14, 2025Report
Jul 23, 2025David J. Taylor (R-OH)Sale$1K–$15KSelfSep 2, 2025Report
Jul 22, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report
Jan 13, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KJointFeb 13, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Medpace Holdings company events

Medpace Holdings filed 6 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 21, 2026.

  1. Oct 21, 2026AnnouncementThe Company’s Board of Directors terminated the Company’s current stock repurchase authorization of the Company’s common stock, $0.01 par value which was set to expire on December 31, 2026. Filing
  2. Jul 22, 2026ResultsReleased financial results. Filing
  3. Jun 4, 2026LeadershipMedpace Holdings, Inc. appointed Brad W. Hansman, age 43, to the position of Executive Vice President, Operations. Filing
  4. May 19, 2026VoteReported shareholder vote results. Filing
  5. Apr 22, 2026LeadershipJesse Geiger notified the Company of his intent to resign as President and that he will retire from the Company effective May 31, 2026. Filing
  6. Feb 9, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Medpace Holdings financials

Famous investors that hold MEDP

9 of the 50 well-known investors we track reported holding MEDP in their latest 13F filing. The largest position is Jim Simons's, worth $282M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026452,428$282M0.4%+9%
Ken Fisher · Fisher Asset ManagementQ3 2026130,522$81.5M0.0%-0%
Ken Griffin · Citadel AdvisorsQ3 2026103,659$64.7M0.0%New
Ray Dalio · Bridgewater AssociatesQ3 202657,506$35.9M0.2%+269%
Israel Englander · Millennium ManagementQ3 202638,775$24.2M0.0%New
Jeremy Grantham · GMOQ3 202634,366$21.5M0.0%+1%
Terry Smith · FundsmithQ3 202625,940$16.2M0.1%-50%
Steve Cohen · Point72 Asset ManagementQ3 202615,812$9.9M0.0%New
Paul Tudor Jones · Tudor Investment CorpQ3 2026846$528K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named MEDP in the last 120 days.

FiledHolderFormStake
Nov 16, 2026T. Rowe Price Associates, Inc.13G/A4.1%
Nov 16, 2026T. Rowe Price Associates, Inc.13G/A4.1%
Nov 13, 2026AQR Capital Management, LLC13G5.0%
Nov 13, 2026AQR Capital Management, LLC13G5.0%

Questions about Medpace Holdings, Inc. (MEDP) stock

Who owns the most MEDP stock?

The largest reported owner of Medpace Holdings, Inc. (MEDP) is BlackRock, Inc., with 8.7% of the company. In total, 695 funds and institutions reported holding MEDP at the end of Q2 2026, together about 87% of the shares. See the largest owners.

Are MEDP insiders buying or selling?

In the last 12 months, MEDP insiders reported no open-market purchases and 50 sales worth $411M. The latest trade was on Oct 29, 2026. See every trade.

What is the short interest in MEDP?

As of Oct 30, 2026, 1.38M MEDP shares were sold short, 4.9% of the shares outstanding, down 14.1% from the report before. At the average daily volume of 399,615 shares, buying them all back would take about 3.5 trading days (days to cover). See the history.

Have members of Congress traded MEDP?

Yes. 4 members of Congress reported 4 purchases and 7 sales of MEDP since Nov 17, 2024. The latest was reported on May 28, 2026. See the trades.

Which famous investors hold MEDP?

9 of the 50 well-known investors we track reported MEDP in their latest 13F filing, including Jim Simons, Ken Fisher, Ken Griffin. The largest position is worth $282M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.